Type 2 Diabetes & Ozempic
A 28-week study looking to clinically compare multiple Ozempic (semaglutide) products.
To Qualify for this Study, you must:
- Participant is 18 – 64 years of age at time of first visit.
- Diagnosed with Type 2 Diabetes ≥ 6 months prior to first visit
- Currently taking Metformin
- Not taking prescribed Ozempic
During the course of the trial, study participants will receive, at no cost:
- Study related medical care
- Study Medication or Placebo
- Compensation for travel
If you feel you may qualify, or would like more information regarding this trial, please contact the study team at (519) 659 – 4040